Institutional Public Private Partnership (IPPP): a high value added funding instrument
Five industry and research associations involved in Institutional Public Private Partnerships (IPPP), known as Joint Undertakings under Horizon 2020, recommend strongly maintaining the public-private partnerships instrument in the next EU Research and Innovation Framework Programme (FP9).
In a joint declaration published on 25 October, co-signed by BIC, the five signatories* highlight the major added value that these partnerships are creating for society, jobs, European market growth and competitiveness.
For more information about the results and impact delivered by the Bio-Based Industries Joint Undertaking since its creation in 2014, read “The BBI JU - An Institutional PPP supporting the Bioeconomy Strategy”.
* The five signatories are:
- AeroSpace and Defence Industries Association of Europe (ASD),
- Bio-based Industries Consortium (BIC)
- European Federation of Pharmaceutical Industries and Associations (EFPIA)
- Hydrogen Europe,
- Association of the European Rail Industry (UNIFE)
